New Imadazopyrazines with CDK9 Inhibitory Activity as Anticancer and Antiviral: Synthesis, In Silico, and In Vitro Evaluation Approaches
This study describes the synthesis and biological activity of new imadazopyrazines as first-in-class CDK9 inhibitors. The inhibition of CDK9 is a well-established therapeutic target in cancer therapy. The new compounds were assessed using an in vitro kinase assay against CDK9. In this assay, compoun...
Wedi'i Gadw mewn:
Prif Awduron: | Aisha A. Alsfouk (Awdur), Hanan M. Alshibl (Awdur), Najla A. Altwaijry (Awdur), Ashwag Alanazi (Awdur), Omkulthom AlKamaly (Awdur), Ahlam Sultan (Awdur), Bshra A. Alsfouk (Awdur) |
---|---|
Fformat: | Llyfr |
Cyhoeddwyd: |
MDPI AG,
2023-07-01T00:00:00Z.
|
Pynciau: | |
Mynediad Ar-lein: | Connect to this object online. |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
Synthesis and Biological Evaluation of Imadazo[1,2-<i>a</i>]pyrazines as Anticancer and Antiviral Agents through Inhibition of CDK9 and Human Coronavirus
gan: Aisha A. Alsfouk, et al.
Cyhoeddwyd: (2022) -
Neurodevelopmental outcomes in children exposed prenatally to levetiracetam
gan: Bshra A. Alsfouk
Cyhoeddwyd: (2022) -
Patterns of antiseizure medication prescription in pregnancy and maternal complications in women with epilepsy: A retrospective study in Saudi Arabia
gan: Bshra A. Alsfouk, et al.
Cyhoeddwyd: (2022) -
Antiseizure medications use during pregnancy and congenital malformations: A retrospective study in Saudi Arabia
gan: Bshra A. Alsfouk, et al.
Cyhoeddwyd: (2021) -
Identification of compounds from Origanum compactum and Origanum elongatum using HPLC/UV-ESI-MS and comparative analysis of their antioxidant, antimicrobial, anticoagulant, and antidiabetic properties
gan: Omkulthom Al Kamaly, et al.
Cyhoeddwyd: (2024)